ERBB2 and breast cancer: According to the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER2), and other indicators in patients, BC could be classified into various molecular subtypes, and corresponding treatment can be given to each subtype.